| Pack NDC# | Product | Strength | Supplied As | Shelf Pack | Inventory |
|---|---|---|---|---|---|
Pack NDC#
0517-6710-10
|
10% Calcium Chloride Injection, USP |
1 Gram (100 mg/mL) |
10 mL |
10 | In Stock |
Pack NDC#
0517-7604-25
|
Acetylcysteine Solution, USP |
20% |
4 mL vial |
25 | In Stock |
Pack NDC#
0517-7504-25
|
Acetylcysteine Solution, USP |
10% |
4 mL vial |
25 | In Stock |
Pack NDC#
0517-9120-25
|
Aminocaproic Acid Injection, USP |
250 mg/mL |
20 mL |
25 | In Stock |
Pack NDC#
0517-9191-25
|
Aminocaproic Acid Injection, USP |
250 mg/mL |
20 mL |
25 | In Stock |
Pack NDC#
0517-1004-25
|
Atropine Sulfate Injection, USP |
0.4 mg/mL |
1 mL |
25 | In Stock |
Pack NDC#
0517-1001-25
|
Atropine Sulfate Injection, USP |
1 mg/mL |
1 mL |
25 | In Stock |
Pack NDC#
0517-0720-01
|
Betamethasone Sodium Phosphate and Betamethasone Acetate Injectable Suspension, USP |
6 mg/mL |
5 mL |
1 | Limited Availability |
Pack NDC#
0517-0791-01
|
Betamethasone Sodium Phosphate and Betamethasone Acetate Injectable Suspension, USP |
6 mg/mL |
5 mL |
1 | Out of Stock |
Pack NDC#
0517-0799-01
|
Betamethasone Sodium Phosphate and Betamethasone Acetate Injectable Suspension, USP |
6 mg/mL |
5 mL |
1 | Out of Stock |
Pack NDC#
0517-2502-10
|
Caffeine and Sodium Benzoate Injection, USP† †Drug is Not FDA-Approved |
250 mg/mL |
2 mL |
10 | In Stock |
Pack NDC#
0517-1820-01
|
Chlorothiazide Sodium For Injection, USP |
500 mg |
Single Dose Vial |
1 | In Stock |
Pack NDC#
0517-0031-25
|
Cyanocobalamin (B12) Injection, USP |
1000 mcg/mL |
1 mL |
25 | In Stock |
Pack NDC#
0517-0130-01
|
Cyanocobalamin (B12) Injection, USP |
1000 mcg/mL |
30 mL |
1 | In Stock |
Pack NDC#
0517-0032-25
|
Cyanocobalamin (B12) Injection, USP |
1000 mcg/mL |
10 mL |
25 | In Stock |
Pack NDC#
0517-1980-05
|
Dicyclomine Hydrochloride Injection, USP |
20 mg/2 mL |
2 mL |
5 | In Stock |
Pack NDC#
0517-9702-25
|
Droperidol Injection, USP |
5 mg/2 mL |
2 mL |
25 | In Stock |
Pack NDC#
0517-1171-10
|
Epinephrine Injection, USP |
1 mg/mL |
1 mL single-dose ampule |
10 | Out of Stock |
Pack NDC#
0517-0420-01
|
Estradiol Valerate Injection, USP |
20 mg/mL |
5 mL |
1 | In Stock |
Pack NDC#
0517-0440-01
|
Estradiol Valerate Injection, USP |
40 mg/mL |
5 mL |
1 | In Stock |
Pack NDC#
0517-0710-01
|
Fomepizole Injection |
1 g/mL |
1.5 mL |
1 | In Stock |
Pack NDC#
0517-4605-25
|
Glycopyrrolate Injection, USP |
0.2 mg/mL |
5 mL |
25 | In Stock |
Pack NDC#
0517-4620-25
|
Glycopyrrolate Injection, USP |
0.2 mg/mL |
20 mL |
25 | In Stock |
Pack NDC#
0517-4601-25
|
Glycopyrrolate Injection, USP |
0.2 mg/mL |
1 mL |
25 | In Stock |
Pack NDC#
0517-4602-25
|
Glycopyrrolate Injection, USP |
0.2 mg/mL |
2 mL |
25 | In Stock |
Pack NDC#
0517-0901-25
|
HydrALAZINE Hydrochloride Injection, USP |
20 mg/mL |
1 mL Single Dose Vial |
25 | In Stock |
Pack NDC#
0517-4201-25
|
Hydroxyzine HCl Injection, USP |
25 mg/mL |
1 mL |
25 | In Stock |
Pack NDC#
0517-5602-25
|
Hydroxyzine HCl Injection, USP |
50 mg/mL |
2 mL |
25 | In Stock |
Pack NDC#
0517-5601-25
|
Hydroxyzine HCl Injection, USP |
50 mg/mL |
1 mL |
25 | In Stock |
Pack NDC#
0517-0650-01
|
Injectafer® (ferric carboxymaltose injection) |
750 mg iron/15 mL |
15 mL |
1 | In Stock |
Pack NDC#
0517-0602-01
|
Injectafer® (ferric carboxymaltose injection) |
100 mg iron/2 mL |
2 mL |
1 | In Stock |
Pack NDC#
0517-1045-05
|
Levocarnitine Injection, USP |
1 gram/5 mL |
5 mL |
5 | In Stock |
Pack NDC#
0517-1075-01
|
Levocarnitine Injection, USP |
4 grams/20 mL |
20 mL |
1 | In Stock |
Pack NDC#
0517-0740-20
|
Methylergonovine Maleate Injection, USP |
0.2 mg/mL |
1 mL |
20 | Out of Stock |
Pack NDC#
0517-9302-25
|
Multrys® (trace elements injection 4*, USP)
*Each mL contains zinc 1,000 mcg, copper 60 mcg, |
* |
1 mL |
25 | In Stock |
Pack NDC#
0517-0735-10
|
niCARdipine Hydrochloride Injection, USP |
2.5 mg/mL |
10 mL |
10 | In Stock |
Pack NDC#
0517-4810-25
|
Nitroglycerin Injection, USP |
5 mg/mL |
10 mL |
25 | Limited Availability |
Pack NDC#
0517-0955-01
|
Olanzapine For Injection |
10 mg/Vial |
Single Use Vial |
1 | Limited Availability |
Pack NDC#
0517-4300-01
|
Paclitaxel Protein-Bound Particles for Injectable Suspension (Albumin bound) |
100 mg/vial |
Single Dose Vial |
1 | In Stock |
Pack NDC#
0517-4002-25
|
Papaverine HCl Injection, USP† †Drug is Not FDA-Approved |
30 mg/mL |
2 mL |
25 | In Stock |
Pack NDC#
0517-0374-05
|
ProvayBlue® (methylene blue) Injection, USP |
50 mg/10 mL |
10 mL |
5 | In Stock |
Pack NDC#
0517-0381-05
|
ProvayBlue® (methylene blue) Injection, USP |
50 mg/10 mL |
10 mL |
5 | In Stock |
Pack NDC#
0517-2051-25
|
Potassium Phosphates Injection, USP |
Phosphorus 15 mmol/5 mL and Potassium 22 mEq/5 mL |
5 mL |
25 | In Stock |
Pack NDC#
0517-2102-25
|
Potassium Phosphates Injection, USP |
Phosphorus 45 mmol/15 mL and Potassium 66 mEq/15 mL |
15 mL |
25 | In Stock |
Pack NDC#
0517-2505-25
|
Potassium Phosphates Injection, USP |
Phosphorus 150 mmol/50 mL and Potassium 220 mEq/50 mL |
50 mL |
25 | In Stock |
Pack NDC#
0517-6560-05
|
Selenious Acid Injection, USP |
600 mcg/10 mL |
10 mL |
5 | In Stock |
Pack NDC#
0517-6502-10
|
Selenious Acid Injection, USP |
12 mcg/2 mL |
2 mL |
10 | In Stock |
Pack NDC#
0517-9305-25
|
Tralement® (trace elements injection 4*, USP)
*Each mL contains zinc 3 mg, copper 0.3 mg, |
* |
1 mL |
25 | In Stock |
Pack NDC#
0517-5810-25
|
Sterile Water For Injection, USP |
- |
10 mL |
25 | Coming Soon |
Pack NDC#
0517-5820-25
|
Sterile Water For Injection, USP |
- |
20 mL |
25 | Coming Soon |
Pack NDC#
0517-5805-25
|
Sterile Water For Injection, USP |
- |
5 mL |
25 | Coming Soon |
Pack NDC#
0517-1020-25
|
Vasopressin Injection, USP |
20 Units/mL |
1 mL |
25 | In Stock |
Pack NDC#
0517-1030-01
|
Vasopressin Injection, USP |
20 Units/mL |
10 mL |
1 | Out of Stock |
Pack NDC#
0517-2310-05
|
Venofer® iron sucrose injection, USP |
200 mg/10 mL |
10 mL |
5 | In Stock |
Pack NDC#
0517-2325-10
|
Venofer® iron sucrose injection, USP |
50 mg/2.5 mL |
2.5 mL |
10 | In Stock |
Pack NDC#
0517-2340-10
|
Venofer® iron sucrose injection, USP |
100 mg/5 mL |
5 mL |
10 | Limited Availability |
|
Pack NDC#
0517-2340-25
|
Venofer® iron sucrose injection, USP |
100 mg/5 mL |
5 mL |
25 | In Stock |
Pack NDC#
0517-6103-25
|
Zinc Sulfate Injection, USP |
3 mg/mL |
10 mL |
25 | Out of Stock |
Pack NDC#
0517-8005-25
|
Zinc Sulfate Injection, USP |
5 mg/mL |
5 mL |
25 | In Stock |
Pack NDC#
0517-6101-25
|
Zinc Sulfate Injection, USP |
1 mg/mL |
10 mL |
25 | In Stock |
News Center
American Regent Receives 2023 Novaplus Program Excellence Award from Vizient
Shirley, NY – September 27, 2023:
American Regent has received a Novaplus Program Excellence Award from Vizient, Inc., the nation’s largest provider-driven health care performance improvement company. The recognition was announced at the 2023 Vizient Connections Summit, held September 18-21 in Las Vegas.
INJECTAFER® Approved in the U.S. for the Treatment of Iron Deficiency in Adult Patients with Heart Failure
Basking Ridge, NJ and Shirley, NY – June 5, 2023: Daiichi Sankyo, Inc. and American Regent, Inc., a Daiichi Sankyo Group company, today announced that the U.S. Food and Drug Administration (FDA) approved INJECTAFER® (ferric carboxymaltose injection) for the treatment of iron deficiency in adult patients with heart failure categorized as New York Heart Association class II/III to improve exercise capacity.
St. John’s University and American Regent Post-Doctoral Pharmaceutical Industry Fellowship Now Recruiting
Melville, NY – September 14, 2023:
Learn more about the St. John’s University and American Regent Post-Doctoral Pharmaceutical Industry Fellowship by downloading our brochure. Information on how to apply to our program as well as key deadlines are included.
Contact Us
By clicking Submit, you confirm that you accept our Privacy Policy and that you agree to your personal contact information being used to contact you and added to our database. If at any time you wish your personal information to be removed from the American Regent® database, please submit a message request to corpcommunications@americanregent.com.